Trader consensus on Polymarket assigns a 93% implied probability to "No" for a new coronavirus pandemic in 2026, driven by the absence of any World Health Organization (WHO) declaration of a pandemic from a coronavirus other than SARS-CoV-2 as of mid-April 2026. Official WHO and CDC surveillance reports confirm no novel betacoronavirus outbreaks with sustained human-to-human transmission meeting Public Health Emergency of International Concern (PHEIC) criteria, despite ongoing SARS-CoV-2 evolution like the BA.3.2 "Cicada" variant detected in wastewater across U.S. states and 20+ countries—variants that do not qualify under market rules. Enhanced global monitoring post-COVID-19, including genomic sequencing, underpins this positioning, with historical precedents like SARS-1 and MERS underscoring rarity. Realistic challenges include an undetected zoonotic spillover rapidly escalating to pandemic levels, though current epidemiological data shows no such signals; watch WHO updates and May 2026 COVID-19 vaccine antigen deliberations for shifts.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गयाNew Coronavirus Pandemic in 2026?
New Coronavirus Pandemic in 2026?
The resolution source will be official announcements from the World Health Organization.
बाज़ार खुला: Jan 6, 2026, 2:40 PM ET
Resolver
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Resolver
0x65070BE91...Trader consensus on Polymarket assigns a 93% implied probability to "No" for a new coronavirus pandemic in 2026, driven by the absence of any World Health Organization (WHO) declaration of a pandemic from a coronavirus other than SARS-CoV-2 as of mid-April 2026. Official WHO and CDC surveillance reports confirm no novel betacoronavirus outbreaks with sustained human-to-human transmission meeting Public Health Emergency of International Concern (PHEIC) criteria, despite ongoing SARS-CoV-2 evolution like the BA.3.2 "Cicada" variant detected in wastewater across U.S. states and 20+ countries—variants that do not qualify under market rules. Enhanced global monitoring post-COVID-19, including genomic sequencing, underpins this positioning, with historical precedents like SARS-1 and MERS underscoring rarity. Realistic challenges include an undetected zoonotic spillover rapidly escalating to pandemic levels, though current epidemiological data shows no such signals; watch WHO updates and May 2026 COVID-19 vaccine antigen deliberations for shifts.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया
बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न